by Daniel Smoot
The CBD industry has been booming in 2019. Yet, it’s far from over.
In fact, it’s expected to rocket another 3,623% over the next three years.
And that’s why Money Morning is bringing you the best CBD stocks to buy today…
The biggest source of news for marijuana stocks in 2019 has undoubtedly been the rush of mergers and acquisitions in the industry.
Mergers and acquisitions can have serious benefits for investors. Companies being purchased can see their share prices skyrocket. The acquirers can benefit from the mergers, creating new synergies for their companies.
by Greg Miller
Here's the deal – in a sector worth $12 billion, consolidation is happening at lightning speed and offering investors opportunities for making money.
However, sometimes these takeover bids can muddy the waters and make things very difficult.
So with stakes this high, it's critical that you understand exactly what's happening in this ongoing story.
Here's Greg with all the details...
by Greg Miller
We've seen some recent downside volatility in the NICI 50 index, causing some investors to panic.
But our Director of Cannabis Investing Research is here to ease your mind and explain that these downturns are only natural.
In fact, cannabis is doing just fine...
It's not easy finding the best marijuana stocks to buy today.
However, we did all the hard work and found a top candidate.
Here is everything you need to know...
The Dow Jones Industrial Average rose 96 points in premarket hours after one of the wildest trading sessions of the year.
The Dow plunged as much as 600 points Thursday before rallying back in the final hours of the trading session.
One of Wall Street's dirtiest tricks is how short sellers can wage vicious public relations campaigns against a company in hopes of driving its share price down.
That's exactly what's happening to one of the best cannabis stocks on the market.
And it's going to backfire spectacularly...
by Greg Miller
In a blistering month for stocks, Aphria has had a particularly bumpy ride.
The Leamington, Canada-based cannabis company was the target of some explosive (and, as we'll see, spurious) allegations from, as it turns out, a firm with substantial short interest. This is a common enough occurrence in the stock market, as Carl Icahn and Bill Ackman's legendary "long vs. short" battle royale over Herbalife Nutrition illustrates.
The short-seller's allegations focus only on Aphria and one other, small company: Toronto, Ont.-based SOL Global Investments. They have nothing to do with other cannabis firms we follow at the National Institute for Cannabis Investors
But, since the short attack and furious price action last week, I wanted everyone to know what's really happening with Aphria.
